4
Changes in Ownership
FENNEC PHARMACEUTICALS INC. Filed Acc 0002043317-26-000002
Chief Commercial Officer acquired 20,679 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Evans Terry L Chief Commercial Officer | 2026-03-31 | Option exercise | +18,456 | 18,456 | D | ||
| Evans Terry L Chief Commercial Officer | 2026-03-31 | Option exercise | +171 | 18,627 | D | ||
| Evans Terry L Chief Commercial Officer | 2026-03-28 | Option exercise | +2,052 | 20,679 | D | ||
| Derivatives | |||||||
| Evans Terry L Chief Commercial Officer | 2026-03-31 | Grant or award · Stock Options | +120,000 | $5.77 | $692,400 | 270,000 | D |
Loading xslF345X06/form4-04022026_040409.xml…